QC Microbiology Tech I
Kite Pharma
Summary
Shift: Sunday through Wednesday, 12:00 PM–10:30 PM
Job description
Job Description
Shift: Sunday through Wednesday, 12:00 PM–10:30 PM
- Perform environmental monitoring of cleanrooms
- Collect water samples to ensure all samples collected per schedule and tested on time
- Perform microbiological assays such as Gram Stain, Endotoxin, Sterility, Microbial Identification, Growth Promotion, Bioburden and Plate Reading
- Data entry and trend data as needed and prepare slides for management
- Routine maintenance of lab equipment and lab spaces
Responsibilities
- Works under close and frequent direction of supervisor
- Perform environmental monitoring of cleanrooms
- Collect water samples to ensure all samples collected per schedule and tested on time
- Perform microbiological assays such as Gram Stain, Endotoxin, Sterility, Microbial Identification, Growth Promotion, Bioburden and Plate Reading
- Aid in filing/archiving of test records
- Data entry and trend data as needed and prepare slides for management
- Assist in investigations regarding out of specifications (OOS) results, address and manage deviations related to micro procedures
- Routine maintenance of lab equipment and lab spaces
- Learns how to troubleshoot and remediate basic microbiological testing-related issues
- Helps maintain a safe work environment by working in accordance with all safety SOPs
- Ensuring assigned tasks are completed on time, while adhering to operational standards and regulatory requirements
- Helps keep lab operations clean and inspection ready
- Additional duties as assigned
Basic Qualifications
- 1+ year of relevant experience and a High School diploma
- Cell therapy experience: 1+ year preferred
Requirements
- 1+ year of relevant experience
- High School diploma
- Cell therapy experience (preferred)
Benefits
- Medical, Dental & Vision
- Life Insurance
- Discretionary Annual Bonus
- Stock-Based Long-Term Incentives
- Paid Time Off
Company overview
Kite Pharma, Inc. is an American biotechnology company specializing in cancer immunotherapy with a primary focus on genetically engineered autologous CAR T cell therapy. Founded in 2009 and headquartered in Santa Monica, California, Kite was acquired by Gilead Sciences in 2017 for $11.9 billion. The company develops cell-based therapies that reengineer a patient's own immune cells to attack and fight cancer cells, representing a personalized approach to cancer treatment. Kite's lead product, Yescarta (axicabtagene ciloleucel), was the first CAR T therapy approved by the FDA for treating adult patients with relapsed or refractory large B-cell lymphoma. With approximately 2,000 employees and manufacturing facilities in California, Maryland, and the Netherlands, Kite operates as an independent company within Gilead Sciences while maintaining its singular focus on advancing cell therapy to treat and potentially cure cancer. The company's innovative approach represents a paradigm shift in cancer treatment, moving away from traditional pharmaceutical manufacturing to individualized cell therapies created one patient at a time.